Premier Pharmacy Labs Inc
Complete recall history across all FDA and CPSC categories — 24 total recalls
Premier Pharmacy Labs Inc appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (24)
FDA drug safety enforcement actions by Premier Pharmacy Labs Inc
| Date | Product | Reason | Class |
|---|---|---|---|
| Jun 18, 2019 | Naloxone HCL Preserved INJ, 500mg/50mL (10mg/mL), 50mL Sterile MDV, Rx only, ... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Phenylephrine HCL PF INJ in 0.9% Sodium Chloride, 1000mcg/10mL (100mgc/mL), *... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Orphenadrine Citrate Sterile Injectable Solution *Contains Sulfites*, 30mg/mL... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Mitomycin Preservative Free Irrigation, 40mg/10mL (4mg/mL), 10mL SDV, Rx only... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Riboflavin 5-Phosphate Sodium Ophthalmic Solution, 19.05mg/3mL (6.35 mg/mL), ... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Isoproterenol HCL in D5W (Sterile to Sterile), 200mcg/50mL (4mcg/mL), 50mL St... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Dexamethasone Sodium Phosphate Preservative Free Sterile Solution for INJ, 24... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJ, 1mL Sterile SDV, Rx only, Premie... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | ChlorproMAZINE HCL INJ, 25mg/mL, *Contains Sulfites*, 1mL in a 5mL Sterile SD... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Atropine Sulfate PF INJ, 0.8 mg/2 mL (0.4 mg/mL), 2mL Single Dose Syringe, Rx... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Isoproterenol HCL in D5W, 500mcg/50mL (10mcg/mL), 50mL Sterile Single-Dose Ba... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Sodium Bicarbonate INJ 8.4%, 50 mEq/50mL (84mg/mL) (1mEq/mL), 50mL Sterile SD... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Isoproterenol HCL in D5W (Non Sterile to Sterile), 200mcg/50mL (4mcg/mL), 50m... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | SUCCINYLcholine Chloride, 200mg/10mL (20mg/mL), 10mL Sterile Single Dose Syri... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | SUCCINYLcholine Chloride, 100mg/5mL (20mg/mL), 5mL Sterile Single-Use Syringe... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Neostigmine Methylsulfate, 5mg/5mL (1mg/mL), 5mL Single Dose Syringe, Rx only... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Brilliant Blue Ophthalmic PF INJ, 0.5mg/mL (0.05%), 1 mL SDV, Rx only, Premie... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Jun 18, 2019 | Droperidol Injectable Sterile Solution, 0.625mg/mL, 1mL in a 3mL Sterile Sing... | Lack of Assurance of Sterility: FDA inspection found insufficient environment... | Class II |
| Apr 11, 2018 | Hydromorphone HCl 1 mg/mL PF INJ. 1mL in a 3mL Sterile Single-Dose Syringe. ... | Lack of Assurance of Sterility:Microbial contamination was detected during ro... | Class II |
| Apr 11, 2018 | Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syri... | Lack of Assurance of Sterility:Microbial contamination was detected during ro... | Class II |
| Apr 11, 2018 | Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syri... | Lack of Assurance of Sterility:Microbial contamination was detected during ro... | Class II |
| Apr 11, 2018 | NEOstigmine Methylsulfate (1 mg/mL) 3mg per 3mL. 3mL Single Dose Syringe. Pre... | Lack of Assurance of Sterility:Microbial contamination was detected during ro... | Class II |
| Jan 11, 2018 | Mitomycin 40 mg/mL Preservative Free Irrigation Volume: 10 mL SDV , Compounde... | Labeling: Label Error on Declared Strength | Class II |
| Aug 10, 2017 | Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Inj... | Stability Date Doesn't Support Expiry: labeling error indicating a beyond use... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.